Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,257
datasets available to search
ShareScore release 0.9.0
Dataset results
1,257 results for “Human infections”
Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
ClinicalTrials.gov study NCT03272347. IPD Sharing: YES. Countries: 4. Publications: 2.
Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men
ClinicalTrials.gov study NCT01422356. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)
ClinicalTrials.gov study NCT04233216. IPD Sharing: YES. Countries: 18. Publications: 1.
Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults
ClinicalTrials.gov study NCT03739866. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
ClinicalTrials.gov study NCT01667731. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
ClinicalTrials.gov study NCT01910402. IPD Sharing: YES. Countries: 13. Publications: 1.
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
ClinicalTrials.gov study NCT03784079. IPD Sharing: YES. Countries: 6. Publications: 1.
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
ClinicalTrials.gov study NCT01384734. IPD Sharing: Not stated. Countries: 10. Publications: 4.
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
ClinicalTrials.gov study NCT02178592. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)
ClinicalTrials.gov study NCT04003103. IPD Sharing: YES. Countries: 3. Publications: 3.
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
ClinicalTrials.gov study NCT01031069. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infect
ClinicalTrials.gov study NCT03060629. IPD Sharing: Not stated. Countries: 5. Publications: 3.
A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults
ClinicalTrials.gov study NCT04871113. IPD Sharing: YES. Countries: 6. Publications: 1.
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
ClinicalTrials.gov study NCT03299049. IPD Sharing: YES. Countries: 13. Publications: 8.
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65
ClinicalTrials.gov study NCT03405935. IPD Sharing: YES. Countries: 5. Publications: 2.
Nor climate, nor human impact factors: Chytrid infection shapes the skin microbiome of an endemic amphibian along a biodiversity hotspot
Open the record for dataset details and reuse information.
Data for: The impact of wildlife and environmental factors on hantavirus infection in host and its translation into human risk
Open the record for dataset details and reuse information.
Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes
Open the record for dataset details and reuse information.
Data from: Competing for blood: the ecology of parasite resource competition in human malaria-helminth co-infections
Ecological theory suggests that co-infecting parasite species can interact within hosts directly, via host immunity and/or via resource competition. In mice, competition for red blood cells (RBCs) between malaria and bloodsucking helminths can regulate malaria population dynamics, but the importance of RBC competition in human hosts was unknown. We analyzed infection density (i.e. the concentration of parasites in infected hosts), from a 2-year deworming study of over 4,000 human subjects. After accounting for resource-use differences among parasites, we find evidence of resource competition, priority effects, and a competitive hierarchy within co-infected individuals. For example, reducing competition via deworming increased Plasmodium vivax densities 2.8-fold, and this effect is limited to bloodsucking hookworms. Our ecological, resource-based perspective sheds new light into decades of conflicting outcomes of malaria-helminth co-infection studies with significant health and transmission consequences. Beyond blood, investigating within-human resource competition may bring new insights for improving human health.
Data from: Evidence of human infection by a new mammarenavirus endemic to Southeastern Asia.
Southeastern Asia is a recognised hotspot for emerging infectious diseases, many of which have an animal origin. Mammarenavirus infections contribute significantly to the human disease burden in both Africa and the Americas, but little data exists for Asia. To date only two mammarenaviruses, the widely spread lymphocytic choriomeningitis virus and the recently described Wēnzhōu virus have been identified in this region, but the zoonotic impact in Asia remains unknown. Here we report the presence of a novel mammarenavirus and of a genetic variant of the Wēnzhōu virus and provide evidence of mammarenavirus-associated human infection in Asia. The association of these viruses with widely distributed mammals of diverse species, commonly found in human dwellings and in peridomestic habitats, illustrates the potential for widespread zoonotic transmission and adds to the known aetiologies of infectious diseases for this region.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.